## Abstract Patients with Parkinson's disease (PD) may have hippocampal atrophy compared with controls. We compared hippocampal, and extra‐hippocampal volumes between PD, PDD (patients with PD who have mild cognitive impairment or dementia), Alzheimer's disease (AD) and controls using volumetric ma
Hippocampal head atrophy predominance in Parkinson’s disease with hallucinations and with dementia
✍ Scribed by N. Ibarretxe-Bilbao; B. Ramírez-Ruiz; E. Tolosa; M. J. Martí; F. Valldeoriola; N. Bargalló; C. Junqué
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 392 KB
- Volume
- 255
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background: There may be a relationship between cognitive impairment and visual hallucinations (VHs) in patients with Parkinson's disease (PD). The objective of this study was to compare the cognitive profile of hallucinating vs. nonhallucinating patients with Parkinson's disease de
## Abstract Parkinson's disease (PD) involves neuropathological changes in the limbic system that lead to neuronal loss and volumetric reductions of several nuclei. We investigated possible volumetric reductions of the amygdala and hippocampus associated to PD. We carried out magnetic resonance ima
## Abstract Age‐related ventricular enlargement is accelerated in Alzheimer's disease, but its relationship to cognitive decline in Parkinson's disease is less clear, even though dementia is common in Parkinson's disease. Our goals were to determine if greater enlargement of the ventricles and gray
## Abstract Volumetric measures of mesial temporal lobe structures on MRI scans recently have been explored as potential biomarkers of dementia in patients with PD, with investigations primarily focused on hippocampal volume. Both __in vivo__ MRI and postmortem tissue studies in Alzheimer's disease